ETC
GMAB icon

Exchange Traded Concepts’s Genmab GMAB Stock Holding History

Exchange Traded Concepts’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,124
Closed -$120K – 1446
2025
Q1 		$120K Sell
6,124
-176
-3% -$3.69K ﹤0.01% 1091
2024
Q4 		$131K Hold
6,300
– – ﹤0.01% 1092
2024
Q3 		$154K Sell
6,300
-874
-12% -$23.4K ﹤0.01% 1059
2024
Q2 		$180K Sell
7,174
-2,230
-24% -$63.2K ﹤0.01% 887
2024
Q1 		$281K Buy
9,404
+5,713
+155% +$168K 0.01% 832
2023
Q4 		$118K Buy
3,691
+936
+34% +$29.4K ﹤0.01% 867
2023
Q3 		$97.2K Sell
2,755
-941
-25% -$35.9K ﹤0.01% 906
2023
Q2 		$140K Buy
+3,696
New +$147K ﹤0.01% 862

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Exchange Traded Concepts's GMAB Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Genmab (GMAB) in Q2 2025, closing a stake of 6,124 shares — an estimated $120K sold.

Exchange Traded Concepts first reported a position in GMAB in Q2 2023 and held it in 8 quarters. The position peaked at $281K in Q1 2024. 217 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Genmab position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 6,124 Genmab shares in Q2 2025, an estimated $120K.
  • Exchange Traded Concepts first reported a position in Genmab in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Genmab position peaked at $281K in Q1 2024.
  • 217 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.